8Outlook for EGFR-Positive Lung Cancer
It is possible to treat lung cancer. Using targeted therapies can help improve the long-term outlook for those diagnosed with EGFR-positive lung cancer. The two-year relative survival rate for non-small cell lung cancer is more than 40 percent, while the five-year relative survival rate is only 25 percent. The exact prognosis can vary from person to person, depending on many factors, such as overall health, age, stage of the cancer at diagnosis, and body response to treatments. Consult your doctor and provide all of the medical information to help them create a clear picture of your outlook. [9]















